These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3156031)

  • 21. Changes in islet microvasculature following streptozotocin-induced beta-cell loss and subsequent replacement in the neonatal rat.
    Nicholson JM; Arany EJ; Hill DJ
    Exp Biol Med (Maywood); 2010 Feb; 235(2):189-98. PubMed ID: 20404034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired in vivo insulin secretion in response to non-glucidic secretagogues in adult rats after neonatal streptozotocin.
    Vicent D; Villanueva-Peñacarrillo ML; Valverde I; Malaisse WJ
    Acta Diabetol; 1994 Sep; 31(3):133-7. PubMed ID: 7827350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic islet blood flow during euglycaemic, hyperinsulinaemic clamp in anaesthetized rats.
    Jansson L; Andersson A; Bodin B; Källskog O
    Acta Physiol (Oxf); 2007 Apr; 189(4):319-24. PubMed ID: 17367401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations between blood glucose levels and bromodeoxyuridine labelling indices of pancreatic islet cells following streptozotocin administration to pregnant Syrian golden hamsters.
    McDowell EM; DeSanti AM; Strum JM
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 57(4):223-30. PubMed ID: 2569782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Destruction of pancreatic beta cells in rats by complete Freund's adjuvant combined with non-diabetogenic doses of streptozotocin.
    Kohnert KD; Odselius R; Fält K; Ziegler B; Ziegler M; Falkmer S
    Diabetes Res; 1987 May; 5(1):1-11. PubMed ID: 2957141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial pancreatectomy in rats causes an impairment of the glucose-induced stimulation of pancreatic islet blood flow.
    Jansson L; Sandler S
    Experientia; 1991 Jun; 47(6):627-9. PubMed ID: 2065764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Islet blood flow in multiple low dose streptozotocin-treated wild-type and inducible nitric oxide synthase-deficient mice.
    Carlsson PO; Flodström M; Sandler S
    Endocrinology; 2000 Aug; 141(8):2752-7. PubMed ID: 10919259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose-induced changes in pancreatic islet blood flow mediated by central nervous system.
    Jansson L; Hellerström C
    Am J Physiol; 1986 Dec; 251(6 Pt 1):E644-7. PubMed ID: 3538897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of nitric oxide synthase by NG-nitro-L-arginine causes a preferential decrease in pancreatic islet blood flow in normal rats and spontaneously diabetic GK rats.
    Svensson AM; Ostenson CG; Sandler S; Efendic S; Jansson L
    Endocrinology; 1994 Sep; 135(3):849-53. PubMed ID: 7520863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial regeneration/proliferation of the beta-cells in the islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats.
    Kanter M; Meral I; Yener Z; Ozbek H; Demir H
    Tohoku J Exp Med; 2003 Dec; 201(4):213-9. PubMed ID: 14690013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-dependent changes of pancreatic islet blood flow in the rat.
    Jansson L; Swenne I
    Int J Pancreatol; 1989 Sep; 5(2):157-63. PubMed ID: 2689526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility of spontaneously hypertensive rats to the diabetogenic effects of streptozotocin.
    Jian K; Fok E; Cam MC; Sambandam N; Yao J; Rodrigues B
    Can J Physiol Pharmacol; 1996 Nov; 74(11):1215-21. PubMed ID: 9028580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New diabetogenic streptozocin analogue, 3-O-methyl-2-([(methylnitrosoamino) carbonyl]amino)-D-glucopyranose. Evidence for a glucose recognition site on pancreatic B-cells.
    Kawada J; Toide K; Nishida M; Yoshimura Y; Tsujihara K
    Diabetes; 1986 Jan; 35(1):74-7. PubMed ID: 2934286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligodeoxynucleotide IMT504: lack of effect on immune parameters during islet regeneration in single dose streptozotocin-induced diabetes.
    Bianchi MS; Calvo V; Chasseing NA; Lago N; Libertun C; Montaner AD; Lux-Lantos VA
    Diabetes Metab Res Rev; 2012 Feb; 28(2):156-63. PubMed ID: 21922635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on sex dependency of B-cell susceptibility to streptozotocin in a rat model of type II diabetes mellitus.
    Ostenson CG; Grill V; Roos M
    Exp Clin Endocrinol; 1989 May; 93(2-3):241-7. PubMed ID: 2528471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in islet blood flow in rats with NIDDM.
    Atef N; Portha B; Pénicaud L
    Diabetologia; 1994 Jul; 37(7):677-80. PubMed ID: 7958538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term insulin treatment prevents the diabetogenic action of streptozotocin in rats.
    Thulesen J; Orskov C; Holst JJ; Poulsen SS
    Endocrinology; 1997 Jan; 138(1):62-8. PubMed ID: 8977386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of streptozotocin on the function of fetal porcine and rat pancreatic (pro-)islets.
    Liu X; Hering BJ; Brendel MD; Bretzel RG
    Exp Clin Endocrinol; 1994; 102(5):374-9. PubMed ID: 7867700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II type 1 receptor antagonists prevent glucose-induced increases in islet blood flow in rats.
    Iwase M; Uchizono Y; Nohara S; Sasaki N; Sonoki K; Iida M
    Scand J Clin Lab Invest; 2009; 69(1):145-50. PubMed ID: 18937099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.